<?xml version="1.0" encoding="utf-8"?>
<File id="26">
  <Title><![CDATA[<p>What is RTS,S?</p>]]></Title>
  <HtmlTextKey><![CDATA[]]></HtmlTextKey>
  <HtmlText><![CDATA[<p>RTS,S is a pre-erythrocytic malaria vaccine candidate. It was the first malaria vaccine candidate to demonstrate in clinical trials that it could help protect young children and infants in malaria-endemic areas of sub-Saharan Africa against infection and clinical disease<sup>(a,b)</sup> caused by <em>Plasmodium falciparum</em>, the most deadly species of the malaria parasite.</p>]]></HtmlText>
  <Topic>BACKGROUND INFORMATION ON MALARIA AND RTS,S</Topic>
  <SubTopic>GENERAL</SubTopic>
  <References><![CDATA[<ol start="1" style="list-style-type: lower-alpha;">
	<li><em>Alonso PL, et al. Lancet 2004; 364: 1411-20.</em></li>
	<li><em>Aponte JJ, et al. Lancet 2007; 370: 1543-51.</em></li>
</ol>]]></References>
  <pdf>xml/content/26/26.pdf</pdf>
  <docx>xml/content/26/26.docx</docx>
  <contentLastUpdated>2013-06-25</contentLastUpdated>
  <RelatedFiles />
</File>